Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Evercore Inc.    EVR

EVERCORE INC.

(EVR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Biotech firm Nkarta's shares more than treble in U.S. debut

share with twitter share with LinkedIn share with facebook
07/10/2020 | 12:33pm EDT

July 10 (Reuters) - Shares of Nkarta Inc more than tripled in value in their U.S. market debut, giving the biotech firm a valuation of $1.61 billion.

Nkarta's robust debut continues the recent trend of a rebound in U.S. investor demand for new listings, after the COVID-19 pandemic had slammed the brakes on market listings.

The company's shares opened at $54.75 and rose to as much as $58.69 in early trade.

Earlier in the day, Nkarta raised $252 million after selling 14 million shares at $18 apiece. The firm had marketed a price range of $16-$17 for its offering.

Nkarta focuses on the discovery, development and commercialization of cell therapies based on natural killer cells to treat cancer. (https://bit.ly/3fiVMim)

The company reported a net loss of $21.1 million in 2019, compared with a net loss of $274,503, a year earlier.

Nkarta said in a filing it would use part of the IPO proceeds to fund its internal discovery research, process development, manufacturing and clinical activities.

Cowen, Evercore ISI, Stifel and Mizuho Securities were the joint underwriters for the IPO. (Reporting by Abhishek Manikandan; Editing by Vinay Dwivedi)

share with twitter share with LinkedIn share with facebook
All news about EVERCORE INC.
08/12Cisco CFO Plans to Step Down
DJ
08/06TREASURIES-Yield curve flattens ahead of U.S. jobs data
RE
08/05EVERCORE : Co-Chairman and Co-CEO Ralph L. Schlosstein to Participate in the UBS..
BU
08/04EVERCORE : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
08/02Drillers Go Remote as Pandemic Reshapes Oil Business
DJ
08/01Oil Giants Post Big Losses, Prepare for Long Slump -- WSJ
DJ
07/31Denbury Resources Files for Bankruptcy, Handing Control to Creditors
DJ
07/31Big Oil Companies Lose Billions, Prepare for Prolonged Pandemic -- 3rd Update
DJ
07/31Offshore-Rig Operator Noble Files for Bankruptcy
DJ
07/31Big Oil Companies Lose Billions, Prepare for Prolonged Pandemic -- 2nd Update
DJ
More news
Financials (USD)
Sales 2020 1 631 M - -
Net income 2020 52,8 M - -
Net Debt 2020 663 M - -
P/E ratio 2020 58,7x
Yield 2020 3,57%
Capitalization 2 639 M 2 639 M -
EV / Sales 2020 2,02x
EV / Sales 2021 1,81x
Nbr of Employees 1 775
Free-Float 53,6%
Chart EVERCORE INC.
Duration : Period :
Evercore Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVERCORE INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 69,00 $
Last Close Price 65,01 $
Spread / Highest target 35,4%
Spread / Average Target 6,14%
Spread / Lowest Target -12,3%
EPS Revisions
Managers
NameTitle
Ralph Lewis Schlosstein Co-Chairman & Co-Chief Executive Officer
John S. Weinberg Co-Chairman & Co-Chief Executive Officer
Roger C. Altman Senior Chairman
Robert B. Walsh Chief Financial Officer
Chris Turek Chief Information Officer & Senior MD
Sector and Competitors
1st jan.Capitalization (M$)
EVERCORE INC.-13.04%2 639
MORGAN STANLEY2.46%82 591
THE GOLDMAN SACHS GROUP, INC.-8.21%76 107
CSC FINANCIAL CO., LTD.71.43%53 834
CITIC SECURITIES COMPANY LIMITED22.89%53 072
THE CHARLES SCHWAB CORPORATION-26.75%44 896